This inventor holds 1 USPTO granted patent. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations by Tatsuo Tozawa in Diagnosing Crohn's Disease
Introduction
Tatsuo Tozawa is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of medical diagnostics, particularly in relation to Crohn's disease. His innovative approach has led to the development of a method and test kit that aids in the diagnosis of this complex condition.
Latest Patents
Tozawa holds a patent for a "Method and test kit for measuring immunoglobulins reactive with amylase as indication of Crohn's disease." This patent describes a method for diagnosing Crohn's disease by detecting the presence of immunoglobulins that react with amylase in a specimen. The method employs immunologic or enzymologic techniques using amylase, along with a test kit designed for this purpose. He has 1 patent to his name.
Career Highlights
Tozawa is associated with Wakamoto Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in medical diagnostics. His work has not only contributed to the understanding of Crohn's disease but has also paved the way for improved diagnostic tools in the medical field.
Collaborations
Throughout his career, Tozawa has collaborated with esteemed colleagues such as Takashi Shimoyama and Masamichi Satomi. These collaborations have fostered a productive environment for innovation and have enhanced the quality of research conducted at Wakamoto Pharmaceutical Co., Ltd.
Conclusion
Tatsuo Tozawa's contributions to the field of medical diagnostics, particularly through his patent related to Crohn's disease, highlight his role as an influential inventor. His work continues to impact the medical community positively, providing valuable tools for diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
